SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Supriya Lifescience informs about change in name of RTA

02 Jan 2025 Evaluate
Supriya Lifescience has informed that the Company has received an email communication from its RTA on December 31, 2024, regarding acquisition of Link Group by Mitsubishi UFJ Trust & Banking Corporation. Consequently, the RTA name has been changed from ‘Link Intime India‘ to ‘MUFG Intime India’ with effect from December 31, 2024. The address and other contact details of the RTA remain unchanged.

The above information is a part of company’s filings submitted to BSE.

Supriya Lifescience Share Price

636.90 -1.05 (-0.16%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×